Zomedica (ZOM) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
21 Apr, 2026Strategic vision and technology innovation
Focus on advancing animal health through practical innovation and expanding digital capabilities, with technology and AI central to growth and improved clinical outcomes.
Five pillars guide decisions: improving pet care, enhancing pet parent satisfaction, streamlining veterinary workflow, supporting veterinarian cash flow, and increasing clinic profitability.
Investment in connected devices, cloud platforms, and AI to unify diagnostics, data, and clinical workflows for better insights and services.
Market trends and digital transformation
AI in animal health projected to grow from $1.57B in 2024 to $7B by 2033, with pet tech and telehealth markets also expanding rapidly.
Zomedica's digital transformation includes MyZomedica platform, mobile apps, e-commerce, and over-the-air software updates, supporting scalable growth.
TRUVIEW AI integration and PIMS (Patient Information Management System) connectivity are key enhancements for workflow and data integration.
Financial performance and guidance
Fourth quarter of 2025 expected to be a record, marking the 20th consecutive quarter of year-on-year revenue growth.
Break-even projected at $55M annualized revenue, with profitability targeted by 2027.
Consumables account for 70-73% of revenue, supporting a recurring revenue model.
Significant operating leverage expected as revenue grows beyond break-even, with no major CapEx needed for current manufacturing scale.
Latest events from Zomedica
- Q1 revenue rose 35% to $8.8M, net loss narrowed, and margins and cash position remained strong.ZOM
Q1 20266 May 2026 - Strong growth and innovation in animal health technology drive expanding market leadership.ZOM
Investor presentation1 May 2026 - Virtual meeting to vote on directors, auditor, executive pay, and by-law amendment; Board is majority independent.ZOM
Proxy filing27 Apr 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and by-law changes.ZOM
Proxy filing24 Apr 2026 - Virtual meeting to vote on directors, auditor, executive pay, and by-law changes; board is majority independent.ZOM
Proxy filing14 Apr 2026 - Record revenue growth and strong margins, with new segments and cost controls driving performance.ZOM
Q4 202516 Mar 2026 - Profitability targeted for 2027, with strong R&D and product innovation fueling growth.ZOM
Status update27 Feb 2026 - Innovative veterinary solutions and recurring revenue drive high growth and margin expansion.ZOM
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - Q2 revenue up 2% to $6.1M, but net loss surged on $16M impairment; margin reached 71%.ZOM
Q2 20241 Feb 2026